This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.94
Shares Outstanding32.5M
Average Volume (10 days)397.8K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.29
Sales (TTM)$1.14
Book Value (MRQ)$0.44
Cash Flow (TTM)$0.24
Cash (MRQ)$0.31

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Thomas Sandgaard
Director, President, CEO and Chairman, Ten Percent Owner
(31,260)
Sell
Aug 19, 2019
Thomas Sandgaard
Director, President, CEO and Chairman, Ten Percent Owner
(100,000)
Sell
Aug 16, 2019
Giuseppe Papandrea
Chief Operating Officer
30,000
Acquire
Jul 22, 2019
Daniel J. Moorhead
Chief Financial Officer
(13,750)
Sell
Jun 12, 2019
Thomas Sandgaard
Director, President, CEO and Chairman, Ten Percent Owner
(40,189)
Sell
Jun 10, 2019

Recent SEC Filings

SC 13D/A
Aug 20, 2019
Insider Buy/Sell
Aug 19, 2019
Company Events
Aug 13, 2019
Company Events
Jul 31, 2019
Quarterly Financials
Jul 31, 2019